1. Home
  2. USNA vs DAWN Comparison

USNA vs DAWN Comparison

Compare USNA & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • DAWN
  • Stock Information
  • Founded
  • USNA 1992
  • DAWN 2018
  • Country
  • USNA United States
  • DAWN United States
  • Employees
  • USNA N/A
  • DAWN N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • USNA Health Care
  • DAWN Health Care
  • Exchange
  • USNA Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • USNA 565.2M
  • DAWN 658.9M
  • IPO Year
  • USNA 1996
  • DAWN 2021
  • Fundamental
  • Price
  • USNA $29.43
  • DAWN $6.71
  • Analyst Decision
  • USNA Hold
  • DAWN Strong Buy
  • Analyst Count
  • USNA 1
  • DAWN 6
  • Target Price
  • USNA $36.00
  • DAWN $30.17
  • AVG Volume (30 Days)
  • USNA 131.4K
  • DAWN 1.3M
  • Earning Date
  • USNA 07-22-2025
  • DAWN 08-05-2025
  • Dividend Yield
  • USNA N/A
  • DAWN N/A
  • EPS Growth
  • USNA N/A
  • DAWN N/A
  • EPS
  • USNA 1.79
  • DAWN N/A
  • Revenue
  • USNA $899,221,000.00
  • DAWN $161,922,000.00
  • Revenue This Year
  • USNA $13.94
  • DAWN $17.98
  • Revenue Next Year
  • USNA $6.51
  • DAWN $49.50
  • P/E Ratio
  • USNA $16.40
  • DAWN N/A
  • Revenue Growth
  • USNA 2.75
  • DAWN N/A
  • 52 Week Low
  • USNA $23.10
  • DAWN $6.08
  • 52 Week High
  • USNA $45.86
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • USNA 41.67
  • DAWN 47.98
  • Support Level
  • USNA $30.10
  • DAWN $6.32
  • Resistance Level
  • USNA $38.32
  • DAWN $7.18
  • Average True Range (ATR)
  • USNA 1.36
  • DAWN 0.29
  • MACD
  • USNA -0.36
  • DAWN 0.01
  • Stochastic Oscillator
  • USNA 4.61
  • DAWN 36.11

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: